Share Price.com
Share Search

Shield Thera Share Price


Share Price: 27.00   Bid / Ask: 25.00 / 29.00   High: 28.10   Low: 26.00



Shield Thera is listed on the London Stock Exchange with ticker code STX, and is part of the Pharmaceuticals & Biotechnology sector. It has a market capitalisation of £33.18 m, with 116,426,000 shares in issue. Over the last year, Shield Thera has traded in a range of 153.40p, peaking at a high of 168.50p, with a low of 15.10p.


Shield Thera Share Price Value

Shield Thera Share Price
Shield Thera
Price27.00
Short CodeSTX
Change Today-1.50
%ge Change-5.26 %
Time07:42:48
High28.10
Low26.00
Open28.50
Yesterdays Close28.50
Volume Traded Today0
Shield Thera Share Price
Intra-day chart for Shield Thera
Shield Thera Intraday Chart
Shield Thera Intraday graph
Shield Thera Intraday Chart


Today’s Trade Volumes for Shield Thera

Recent Trades for STX

Recent Share Trades for Shield Thera (STX) (streaming)

Date
Time
Trade Prc
Volume
Value (approx)
22-May-18
16:39:52
26.00
25,000
6,500
22-May-18
16:32:40
28.00
2,500
700.00
22-May-18
14:14:10
28.00
2,173
608.44
22-May-18
08:45:25
28.00
4,754
1,331
22-May-18
08:45:25
28.00
-4,797
-1,343
22-May-18
08:45:25
28.00
4,797
1,343
22-May-18
08:35:34
28.10
1,779
499.90
21-May-18
12:18:54
28.00
5,000
1,400
21-May-18
09:10:11
28.20
333
93.91


6 Month Graph for Shield Thera

Shield Thera 6 month graph

Share News for Shield Thera

HeadlineDate
Shield Therapeutics losses deepen, to cut headcount and promotional spending11 Apr '18
Shield Therapeutics to re-submit US drug application without more trials6 Apr '18
Shield Therapeutics gets extended European approval for iron-deficiency treatment27 Mar '18
Shield Therapeutics awaits FDA opinion on alteration to clinical study results16 Mar '18
Shield Therapeutics gets European nod for iron deficiency treatment23 Feb '18
Shield Therapeutics cuts costs ahead of Feraccru decision22 Feb '18
FTSE remains weak on rate concerns but US steadies5 Feb '18
FTSE hit by global sell-off5 Feb '18
Shield Therapeutics clinical trial fails to meet objectives5 Feb '18
Shield Therapeutics readies drug study10 Oct '17



Useful information about Shield Thera



Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.